Business
CURE Pharmaceutical Announces Crosslink Patent for Covering Company’s Proprietary CureFilm™ Drug Delivery Technology
CURE Pharmaceutical Announces Crosslink Patent for Covering Company’s Proprietary CureFilm™ Drug Delivery Technology.
About this update from Avenir Wellness Solutions Inc.
[{"type":"text","content":"\n\n OXNARD, Calif., May 18, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTCQB:CURR), (“CURE”), a leading disruptive drug delivery technology and pharmaceutical cannabinoid molecule development company, announced today publication by the Unites States Patent and Trademark Office (USPTO) of its Patent application entitled “Pharmaceutical Composition with Ionically Crosslinked Polymer Encapsulation of Active Ingredient.” This patent application, which has been assigned USPTO publication number US-2017-0100327 to CURE Pharmaceutical, covers the Company’s proprietary CureFilm™ drug delivery technology.\n “This publication by the USPTO of our Crosslink patent is an important step in the application process, moving us closer to our goal of approval and issuance of this patent,” said Rob Davidson, CEO of CURE. “This is yet another milestone in the advances CURE continues to make in our technology platform, taking our product capabilities to even higher levels, allowing us to offer highly effective products that contain precisely controlled levels of an active or multiple actives in a stable, convenient and practical platform.” The patent, which covers compositions and thin films containing an encapsulated pharmaceutical ingredient, as well as methods of manufacturing and using the same, allows for better stability and delivery into the lower GI system, increasing the potential for absorption into the blood without degradation of the active ingredient. It also allows for the combination of active pharmaceutical ingredients on one thin film without negative interaction. CURE's intellectual property (IP) development strategy focuses on improving product integrity, efficiency and load capacity for all drug delivery technologies. CURE has protected these innovations using a blended strategy of patents, trade secrets and proprietary equipment design. CURE has a broad and growing patent portfolio, with several patents issued and pending:  PATENTS ISSUED  SLW File NumberTitleApplication NumberPatent Number3768.003US2METHOD AND APPARATUS FOR MINIMIZING HEAT, MOISTURE, AND SHEAR DAMAGE TO MEDICANTS AND OTHER COMPOSITIONS DURING INCORPORATION OF SAME WITH EDIBLE11/836,758US 8,840, 919 B23768.007US1METHODS FOR MODULATING DISSOLUTION, BIOAVAILABILITY, BIOEQUIVALENCE, AND D...